Peter Lynch · Growth at a reasonable price (GARP)
Is Cohen & Steers, Inc. (CNS) a Peter Lynch Stock?
Does not fit Lynch's GARP criteria, growth too low or price too high.
21/100
No encaja
2/6 criterios cumplidos
Los criterios de Peter Lynch, aplicados a CNS
PEG ≤ 1.0
clave-
EPS CAGR ≥ 15%
clave-9.1%
Revenue CAGR ≥ 10%
-0.7%
Net margin > 0
27.1%
Cómo se valora CNS en otras estrategias
Datos financieros en vivo
Cap. mercado
$3.75B
PER (TTM)
23.8x
ROIC (TTM)
43.5%
Margen bruto
66.41%
Otros análisis Peter Lynch
Preguntas frecuentes
What is CNS's Peter Lynch fit score?
CNS scores 21/100 on our Peter Lynch fit engine. Does not fit Lynch's GARP criteria, growth too low or price too high.
Does Peter Lynch actually own CNS?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends CNS.
How often is this score updated?
CNS's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Peter Lynch posea o recomiende CNS personalmente.
